Incyte Corporation vs Southwest Airlines Co — how do they compare? Incyte Corporation trades at $115.7 (market cap $23.11B), while Southwest Airlines Co trades at $48.24 (market cap $23.63B). The key difference: Incyte Corporation and Southwest Airlines Co are close in size by market cap, and Southwest Airlines Co pays a 1.49% dividend while Incyte Corporation pays none. Which is the better fit depends on your goals.
| INCY | LUV | |
|---|---|---|
Market Cap | $23.11B | $23.63B |
Sector | Health | Industrials |
52-Week High | $118.52 | $54.80 |
52-Week Low | $67.38 | $29.06 |
Enterprise Value | $19.13B | $26.70B |
Dividend Yield | — | 1.49% |
Trailing returns across standard periods
Latest headlines on both assets
Incyte focuses on the discovery and development of small-molecule drugs. The firm's lead drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis. Incyte's pipeline includes a broad array of oncology and dermatology programs.
Read more on INCY →Southwest Airlines is the largest domestic carrier in the United States, as measured by the number of originating passengers boarded. Southwest operates over 700 aircraft in an all-Boeing 737 fleet. Despite expanding into longer routes and business travel, the airline still specializes in short-haul leisure flights, using a point-to-point network. Southwest operates a low-cost carrier business model.
Read more on LUV →